KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) EBIT Margin (2016 - 2025)

Repligen (RGEN) has disclosed EBIT Margin for 16 consecutive years, with 12.23% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 956.0% to 12.23% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.77%, a 731.0% increase, with the full-year FY2025 number at 1.77%, up 731.0% from a year prior.
  • EBIT Margin was 12.23% for Q4 2025 at Repligen, down from 8.91% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 30.42% in Q2 2022 to a low of 69.51% in Q4 2022.
  • A 5-year average of 1.46% and a median of 5.75% in 2025 define the central range for EBIT Margin.
  • Biggest YoY gain for EBIT Margin was 4337bps in 2023; the steepest drop was -2291bps in 2023.
  • Repligen's EBIT Margin stood at 52.31% in 2021, then plummeted by -33bps to 69.51% in 2022, then skyrocketed by 62bps to 26.14% in 2023, then rose by 17bps to 21.79% in 2024, then surged by 44bps to 12.23% in 2025.
  • Per Business Quant, the three most recent readings for RGEN's EBIT Margin are 12.23% (Q4 2025), 8.91% (Q3 2025), and 7.62% (Q2 2025).